Lowering of elevated tissue PCO2in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties
Source abstract
Abstract
Even though erythrocytes transport both oxygen and carbon dioxide, research on blood substitutes has concentrated on the transport of oxygen and its vasoactivity and oxidative effects. Recent study in a hemorrhagic shock animal model shows that the degree of tissue PCO(2) elevation is directly related to mortality rates. We therefore prepared a novel nanobiotechnological carrier for both O(2) and CO(2) with enhanced antioxidant properties. This is based on the use of glutaraldehyde to crosslink stroma free hemoglobin (SFHb), superoxide dismutase (SOD), catalase (CAT) and carbonic anhydrase (CA) to form a soluble PolySFHb-SOD-CAT-CA. It was compared to blood and different resuscitation fluids on the ability to lower elevated tissue PCO(2) in a 2/3 blood volume loss rat hemorrhagic shock model. Sixty minutes of sustained hemorrhagic shock at 30 mm Hg resulted in the increase of tissue PCO(2) to 95 mm ± 3 mmHg from the control level of 55 mm Hg. Reinfusion of whole blood (Hb 15 g/dL with its RBC enzymes) lowered the tissue PCO2 to 72 ± 4.5 mmHg 60 minutes after reinfusion. PolySFHb-SOD-CAT-CA (SFHb 10 g/dL plus additional enzymes) was more effective than whole blood in lowering PCO(2) lowering this to 66.2 ± 3.5 mmHg. Ringer's Lactated solution or polyhemoglobin lowered the elevated PCO2 only slightly to 87 ± 4.5 mmHg and 84.8 ± 1.5 mmHg, respectively. Moreover, ST-elevation for whole blood (Hb 15 g/dL) and PolySFHb-SOD-CAT-CA (Hb 10 g/dL) was respectively 12.8% ± 4% and 13.0% ± 2% of the control 60 minutes after reinfusion. Both are significantly better than those in the Ringer's lactated group and the PolyHb group. In conclusion, this novel approach for blood substitute design has resulted in a novel nanobiotechnological carrier for both O(2) and CO(2) with enhanced antioxidant properties.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Heme Oxygenase-1 and Carbon Monoxide · Nitric Oxide and Endothelin Effects
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (20)
Show source-provided references
1. Bian Y · Artif Cells Blood Substit Biotechnol · 2011 · 39 · 12710.3109/10731199.2011.581052 ↗
2. Chang EJ · Transplant Proc · 2004 · 36 · 195210.1016/j.transproceed.2004.08.146 ↗
3. Chang TMS · Science · 1964 · 146 · 52410.1126/science.146.3643.524 ↗
4. Chang TMS · Biochem Biophys Res Com · 1971 · 44 · 153110.1016/S0006-291X(71)80260-7 ↗
5. Chang TMS. 2007. Monograph on Artificial cells: Biotechnology, Nanotechnology, Blood Substitutes, Regenerative Medicine, Bioencapsulation, Cell/Stem Cell Therapy. Singapore/London: World Science Publisher/Imperial College Press, p. 454 (available free online at www.artcell.mcgill.ca).
6. Chang TMS · Crit Care Clin · 2009 · 25 · 37310.1016/j.ccc.2008.12.006 ↗
7. Chang TMS · Artif Cells Blood Immobil Substit Biotechnol · 2012 · 40 · 19710.3109/10731199.2012.662408 ↗
8. D’Agnillo D · Nat Biotechnol · 1998 · 16 · 66710.1038/nbt0798-667 ↗
9. Geers C · Physiol Rev · 2000 · 80 · 68110.1152/physrev.2000.80.2.681 ↗
10. Jahr JS · J Traum · 2008 · 64 · 148410.1097/TA.0b013e318173a93f ↗
11. Kvarstein G · Crit Care Med · 2004 · 32 · 23210.1097/01.CCM.0000104948.41544.FC ↗
12. Liu Q · Artif Cells Blood Substit Biotechnol · 2008 · 36 · 16910.1080/10731190802123822 ↗
13. Moore E · J Am Coll Surg · 2009 · 208 · 110.1016/j.jamcollsurg.2008.09.023 ↗
14. Powanda D · Artif Cells Blood Substit Immobil Biotechnol · 2002 · 30 · 2310.1081/BIO-120002725 ↗
15. Sims C · J Trauma · 2001 · 51 · 113710.1097/00005373-200112000-00020 ↗
16. Tronstad C · Physiol Meas · 2010 · 31 · 124110.1088/0967-3334/31/9/013 ↗
17. Walter FB · Biochimica Et Biophysica Acta · 2010 · 1804 · 41010.1016/j.bbapap.2009.10.021 ↗
18. Winslow R. · 2006
19. 10.1097/ALN.0b013e3181cd783810.1097/ALN.0b013e3181cd7838 ↗
20. Zapol W · Artif Cells Blood Substit Biotechnol · 2012 · 40 · 19710.3109/10731199.2012.662408 ↗